Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in PBYI — Puma Biotechnology, Inc.

CIK 1692234 Seattle, WA
Back to PBYI Full portfolio

Position in PBYI

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$2,207,817
+$599,755 QoQ
Shares Held
272,234
+8.2% QoQ
Ownership
0.527%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 160 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PBYI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. PBYI ranks #84 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in PBYI

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,207,817 272,234
2026-03-31 $1,608,062 251,653
2025-12-31 $1,497,334 251,653
2025-09-30 $5,122,519 964,693
2025-06-30 $68 20
2025-03-31 $61,843 20,893
2024-12-31 $61 20
2024-09-30 $51 20
2024-06-30 $65 20
2022-09-30 $234,959 99,139
2022-06-30 $342,282 120,099
2022-03-31 $497,468 172,732
2021-12-31 $294,638 96,921
2021-09-30 $2,542,322 362,671
2021-06-30 $125,839 13,708
2021-03-31 $1,258,049 129,429
2020-12-31 $1,497,014 145,908
2020-09-30 $1,890,874 187,401
2020-06-30 $1,439,766 138,041
2020-03-31 $623,986 73,932